Broxmeyer H E, Sherry B, Cooper S, Lu L, Maze R, Beckmann M P, Cerami A, Ralph P
Department of Medicine (Hematology/Oncology), Indiana University School of Medicine, Indianapolis 46202.
J Immunol. 1993 Apr 15;150(8 Pt 1):3448-58.
Macrophage inflammatory protein (MIP)-1 alpha, part of a family termed chemokines, has been implicated in suppression of hemopoietic stem and progenitor cell proliferation. The chemokine family has been organized into two subgroups with MIP-1 alpha, MIP-1 beta, macrophage chemotactic and activating factor (MCAF) and RANTES belonging to one subgroup, and GRO-alpha, MIP-2 alpha (GRO-beta), MIP-2 beta (GRO-gamma), platelet factor 4 (PF4), IL-8, and neutrophil activating peptide (NAP)-2 belonging to the other. These molecules were evaluated for effects on colony formation by human bone marrow multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. None of the chemokines stimulated colony formation in the absence of CSF, or influenced colony formation stimulated by a single growth factor such as granulocyte-macrophage-CSF or erythropoietin. However, MIP-1 alpha, MIP-2 alpha, PF4, IL-8, and MCAF suppressed in dose-response fashion colony formation of immature subsets of myeloid progenitor cells stimulated by GM-CSF plus steel factor. Effects were apparent on low density and CD34 HLA-DR(+)-sorted marrow cells in which up to 88.4% of the cells were composed of progenitor cells, suggesting direct effects on the progenitors themselves. Up to 2500-fold less of each chemokine could be used to demonstrate synergistic suppression when any two of these five chemokines were used together at low concentrations, effects also apparently directly on the progenitors. In contrast, MIP-1 beta, MIP-2 beta, GRO-alpha, NAP-2, and RANTES were not suppressive nor did they synergize with MIP-1 alpha, MIP-2 alpha, PF4, IL-8, or MCAF to suppress. However, a fivefold excess of MIP-1 beta blocked the suppressive effects of MIP-1 alpha. Similarly, a fivefold excess of either MIP-2 beta or GRO-alpha blocked the suppressive effects of IL-8 and PF4. These suppressing, synergizing and blocking effects may be of relevance to blood cell regulation.
巨噬细胞炎性蛋白(MIP)-1α是趋化因子家族的一部分,与造血干细胞和祖细胞增殖的抑制有关。趋化因子家族已被分为两个亚组,MIP-1α、MIP-1β、巨噬细胞趋化和激活因子(MCAF)以及调节激活正常T细胞表达和分泌因子(RANTES)属于一个亚组,而生长调节致癌基因-α(GRO-α)、MIP-2α(GRO-β)、MIP-2β(GRO-γ)、血小板因子4(PF4)、白细胞介素-8(IL-8)和中性粒细胞激活肽(NAP)-2属于另一个亚组。评估了这些分子对人骨髓多能(CFU-GEMM)、红系(BFU-E)和粒细胞-巨噬细胞(CFU-GM)祖细胞集落形成的影响。在没有集落刺激因子(CSF)的情况下,这些趋化因子均未刺激集落形成,也未影响由单一生长因子如粒细胞-巨噬细胞集落刺激因子(GM-CSF)或促红细胞生成素刺激的集落形成。然而,MIP-1α、MIP-2α、PF4、IL-8和MCAF以剂量反应方式抑制了GM-CSF加干细胞因子刺激的髓系祖细胞未成熟亚集的集落形成。对低密度和CD34 HLA-DR(+)分选的骨髓细胞有明显影响,其中高达88.4%的细胞由祖细胞组成,表明对祖细胞本身有直接影响。当这五种趋化因子中的任意两种以低浓度共同使用时,每种趋化因子的用量可减少多达2500倍来证明协同抑制作用,其作用显然也直接作用于祖细胞。相比之下,MIP-1β、MIP-2β、GRO-α、NAP-2和RANTES既没有抑制作用,也不会与MIP-1α、MIP-2α、PF4、IL-8或MCAF协同发挥抑制作用。然而,五倍过量的MIP-1β可阻断MIP-1α的抑制作用。同样,五倍过量的MIP-2β或GRO-α可阻断IL-8和PF4的抑制作用。这些抑制、协同和阻断作用可能与血细胞调节有关。